Pneumococcal Conjugate Vaccine (PCV) 13

Pneumococcal disease is a serious bacterial infection that can lead to severe health complications, including meningitis, pneumonia, and sepsis. While it affects people of all ages, older adults and those with certain health conditions are at a higher risk of experiencing severe illness. Fortunately, pneumococcal vaccines offer an effective way to prevent these life-threatening infections. These vaccines protect against specific strains of pneumococcal bacteria. They are commonly used for infants, children, and certain adults at higher risk of disease.

ADULT VACCINATION:

Pneumococcal Conjugate Vaccination (PCV 13)

13 serotypes of Streptococcus Pneumonia (1,3,4,5, 6A,6B, 7F, 9V, 14 19F, 18C and 23F)

AGE:

N/A

DOSE AND INTERVAL:

1 dose

DOSAGE AND ADMINISTRATION:

0.5 mL Intramuscularly (IM)

*  Given intramuscularly (IM)

*  Recommended for adults and children 6 years or older with certain medical conditions if they did not already receive PCV13

*  19 through 64 years old who have certain medical conditions or who smoke.

   - Give 1 dose of PCV13 and 1 dose of PPSV23.

   Administer PCV13 first, then give the PPSV23 dose at least 8 weeks later.

CDC recommends PCV 13 for: 

*  All babies and children younger than 5 years old

*  Children 5 through 18 years old with certain medical conditions that increase their risk of pneumococcal disease

*  Adults 65 years or older

*  Adults 19 through 64 years old with certain medical conditions or risk factors